Salvatore Petta

29.4k total citations · 6 hit papers
256 papers, 11.2k citations indexed

About

Salvatore Petta is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Salvatore Petta has authored 256 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 232 papers in Epidemiology, 152 papers in Hepatology and 45 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Salvatore Petta's work include Liver Disease Diagnosis and Treatment (221 papers), Hepatitis C virus research (88 papers) and Liver Disease and Transplantation (58 papers). Salvatore Petta is often cited by papers focused on Liver Disease Diagnosis and Treatment (221 papers), Hepatitis C virus research (88 papers) and Liver Disease and Transplantation (58 papers). Salvatore Petta collaborates with scholars based in Italy, United Kingdom and France. Salvatore Petta's co-authors include Antonio Craxı̀, Calogero Cammà, V. Di Marco, Giulio Marchesini, Daniela Cabibi, Elisabetta Bugianesi, Luca Valenti, Emmanuel Tsochatzis, Stefania Grimaudo and Laurent Castéra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Salvatore Petta

248 papers receiving 11.0k citations

Hit Papers

EASL Clinical Practice Guidelines on non-in... 2016 2026 2019 2022 2021 2016 2018 2019 2023 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
    2021 950 citations Emmanuel Tsochatzis, Salvatore Petta et al. profile →
  2. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
    2016 581 citations Salvatore Petta, Manuel Romero‐Gómez et al. profile →
  3. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation
    2018 300 citations Salvatore Petta et al. profile →
  4. Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
    2019 240 citations Elisabetta Bugianesi, Salvatore Petta et al. Hepatology profile →
  5. MAFLD: a multisystem disease
    2023 118 citations Rosaria Maria Pipitone, Claudia La Mantia et al. profile →
  6. The first MASH drug therapy on the horizon: Current perspectives of resmetirom
    2024 82 citations Salvatore Petta, Giovanni Targher et al. Liver International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salvatore Petta Italy 61 9.4k 5.6k 3.0k 1.5k 1.3k 256 11.2k
Mohammed Eslam Australia 37 8.4k 0.9× 3.9k 0.7× 3.3k 1.1× 1.1k 0.7× 1.2k 0.9× 123 9.6k
Aijaz Ahmed United States 53 7.8k 0.8× 5.5k 1.0× 2.1k 0.7× 1.8k 1.3× 1.2k 0.9× 322 10.7k
Mazen Noureddin United States 49 7.1k 0.8× 3.9k 0.7× 2.7k 0.9× 1.3k 0.9× 932 0.7× 272 9.1k
Manuel Romero‐Gómez Spain 55 11.1k 1.2× 8.0k 1.4× 3.0k 1.0× 2.5k 1.7× 1.2k 0.9× 375 14.7k
Mattias Ekstedt Sweden 31 7.9k 0.8× 4.0k 0.7× 3.2k 1.1× 1.1k 0.8× 1.4k 1.1× 102 8.7k
Sven Francque Belgium 48 7.3k 0.8× 3.2k 0.6× 2.9k 1.0× 1.5k 1.0× 801 0.6× 194 9.1k
Naim Alkhouri United States 59 8.7k 0.9× 3.8k 0.7× 3.9k 1.3× 1.9k 1.3× 864 0.6× 325 11.2k
Emmanuel Tsochatzis United Kingdom 55 12.1k 1.3× 9.4k 1.7× 2.5k 0.9× 3.4k 2.3× 1.3k 0.9× 308 15.8k
Jörn M. Schattenberg Germany 50 6.7k 0.7× 3.4k 0.6× 2.5k 0.9× 1.5k 1.0× 953 0.7× 332 9.2k
Stefano Bellentani Italy 43 10.8k 1.2× 4.4k 0.8× 5.2k 1.7× 1.6k 1.1× 2.8k 2.1× 105 12.8k

Countries citing papers authored by Salvatore Petta

Since Specialization
Citations

This map shows the geographic impact of Salvatore Petta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Petta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Petta more than expected).

Fields of papers citing papers by Salvatore Petta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvatore Petta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Petta. The network helps show where Salvatore Petta may publish in the future.

Co-authorship network of co-authors of Salvatore Petta

This figure shows the co-authorship network connecting the top 25 collaborators of Salvatore Petta. A scholar is included among the top collaborators of Salvatore Petta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvatore Petta. Salvatore Petta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pugliese, Nicola, Federica Cerini, Rosa Lombardi, et al.. (2025). Key Predictors of Relevant Weight Loss in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease. United European Gastroenterology Journal. 13(7). 1205–1216. 1 indexed citations
2.
Petta, Salvatore, Giovanni Targher, Stefano Romeo, et al.. (2024). The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver International. 44(7). 1526–1536. 82 indexed citations breakdown →
3.
Mantovani, Alessandro, Stefano Bonapace, Salvatore Petta, et al.. (2024). MASLD Is Associated With an Increased Long‐Term Risk of Atrial Fibrillation: An Updated Systematic Review and Meta‐Analysis. Liver International. 45(1). e16128–e16128. 10 indexed citations
4.
Ciminnisi, Stefania, et al.. (2024). Food Beliefs and the Risk of Orthorexia in Patients with Inflammatory Bowel Disease. Nutrients. 16(8). 1193–1193. 6 indexed citations
5.
Pugliese, Nicola, Davide Polverini, Rosa Lombardi, et al.. (2024). Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility. Journal of Personalized Medicine. 14(6). 568–568. 6 indexed citations
6.
Cabibi, Daniela, Antonino Giulio Giannone, Vincenza Calvaruso, et al.. (2024). Quantitative Evaluation by Digital Pathology of Immunohistochemical Expression of CK7, CK19, and EpCAM in Advanced Stages of NASH. Biomedicines. 12(2). 440–440. 1 indexed citations
7.
Forlano, Roberta, Sahan Jayawardana, Benjamin H. Mullish, et al.. (2023). A prospective study on the prevalence of MASLD in people with type‐2 diabetes in the community. Cost effectiveness of screening strategies. Liver International. 44(1). 61–71. 23 indexed citations
8.
Dalbeni, Andrea, Rosa Lombardi, Grazia Pennisi, et al.. (2023). Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis. Hepatology. 79(5). 1107–1116. 17 indexed citations
9.
Pennisi, Grazia, Ciro Celsa, Marco Enea, et al.. (2022). Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis. Nutrition Metabolism and Cardiovascular Diseases. 32(10). 2279–2288. 17 indexed citations
10.
Sasso, Ferdinando Carlo, Pia Clara Pafundi, Alfredo Caturano, et al.. (2021). Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes. Nutrition Metabolism and Cardiovascular Diseases. 31(8). 2345–2353. 44 indexed citations
11.
Pugliese, Nicola, Maria Corina Plaz Torres, Salvatore Petta, et al.. (2021). Is there an ‘ideal’ diet for patients with NAFLD?. European Journal of Clinical Investigation. 52(3). e13659–e13659. 45 indexed citations
12.
Kondili, Loreta A., Ivane Gamkrelidze, Sarah Blach, et al.. (2020). Optimization of hepatitis C virus screening strategies by birth cohort in Italy. Liver International. 40(7). 1545–1555. 31 indexed citations
13.
Vincentis, Antonio De, Rosellina Margherita Mancina, Jussi Pihlajamäki, et al.. (2020). Genetic variants in the MTHFR are not associated with fatty liver disease. Liver International. 40(8). 1934–1940. 7 indexed citations
14.
Ferrarese, Alberto, Maria Cristina Morelli, Paola Carrai, et al.. (2020). Outcomes of Liver Transplant for Adults With Wilson’s Disease. Liver Transplantation. 26(4). 507–516. 14 indexed citations
15.
Liu, Feng, George Boon‐Bee Goh, Dina Tiniakos, et al.. (2019). qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis. Hepatology. 71(6). 1953–1966. 82 indexed citations
16.
Pennisi, Grazia, Ciro Celsa, Federica Spatola, et al.. (2019). Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives. International Journal of Environmental Research and Public Health. 16(22). 4334–4334. 23 indexed citations
17.
Petta, Salvatore, Francesca Rini, Vincenza Calvaruso, et al.. (2019). Aminopyrine breath test predicts liver‐related events and death in HCV‐related cirrhosis on SVR after DAA therapy. Liver International. 40(3). 530–538. 1 indexed citations
18.
Buzzetti, Elena, Salvatore Petta, Tu Vinh Luong, et al.. (2019). Evaluating the association of serum ferritin and hepatic iron with disease severity in non‐alcoholic fatty liver disease. Liver International. 39(7). 1325–1334. 71 indexed citations
19.
Novo, Giuseppina, Lydia Giannitrapani, Salvatore Petta, et al.. (2018). Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study. Alimentary Pharmacology & Therapeutics. 48(7). 740–749. 14 indexed citations
20.
Cabibi, Daniela, Giuseppe Cabibbo, Calogero Cammà, et al.. (2014). Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C. Default journal. 61. 523–529. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammed Eslam Breakdown of academic impact, for papers by Aijaz Ahmed Breakdown of academic impact, for papers by Mazen Noureddin Breakdown of academic impact, for papers by Manuel Romero‐Gómez Breakdown of academic impact, for papers by Mattias Ekstedt Breakdown of academic impact, for papers by Sven Francque Breakdown of academic impact, for papers by Naim Alkhouri Breakdown of academic impact, for papers by Emmanuel Tsochatzis Breakdown of academic impact, for papers by Jörn M. Schattenberg Breakdown of academic impact, for papers by Stefano Bellentani
Rankless by CCL
2026